US state expands Rx drug database
The Governor of the US state of Virginia, Tim Kaine (Democrat), has announced a $400,000 federal grant to upgrade a prescription drug tracking database. This allows pharmacists and physicians to identify patients who make excessive prescription requests within the state, which has a significant prescription drug abuse problem, especially in the south west of the state, according to the Roanoake Times.
Among the commonly-abused drugs recorded in the Virginian database are methadone, OxyContin (oxycondone HCl), a powerful prescription pain reliever marketed by drugmaker Purdue Frederick and Abbott Laboratories' Vicodin (hydrocodone 10mg, paracetamol 1g).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze